Correspondence to editorial 1 on "Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues".
APA
Huang R, Nguyen MH (2026). Correspondence to editorial 1 on "Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues".. Clinical and molecular hepatology, 32(1), e83-e84. https://doi.org/10.3350/cmh.2025.0479
MLA
Huang R, et al.. "Correspondence to editorial 1 on "Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues".." Clinical and molecular hepatology, vol. 32, no. 1, 2026, pp. e83-e84.
PMID
40339594
같은 제1저자의 인용 많은 논문 (5)
- miR-596 as a novel prognostic biomarker and tumor suppressor in breast cancer through targeting EIF5AL1.
- Combining AI to reveal CCDC3-mediated pathways of colorectal cancer liver metastasis.
- Kaixuan Qibi granules attenuate myocardial fibrosis through BRD4 blockade regulated by the NF-κB/NLRP3 signaling pathway.
- Pretreatment emotional distress and peripheral biomarkers predict immune checkpoint inhibitor response in people with advanced inoperable gastroesophageal cancer.
- Correspondence to editorial 2 on "Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues".